Clinical Trial Results: LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing LOC (local/regional) therapy versus systemic therapy in patients with BCLC stage B hepatocellular carcinoma; study terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LOcoregional

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2026-06-18